[Percutaneous treatment in rheumatic diseases].
D004338:Drug Combinations; D004341:Drug Evaluation; D004952:Esters / Q000627:therapeutic use; D005026:Ethylene Glycols / Q000627:therapeutic use*; D006801:Humans; D010936:Plant Extracts / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012459:Salicylates
D004338:Drug Combinations; D004952:Esters; D005026:Ethylene Glycols; D010936:Plant Extracts; D012459:Salicylates
Perkutane Behandlung bei rheumatischen Erkrankungen.